| 存储条件 |
|---|
| Product Name | Anti-BRCA1 antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Polypeptide |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | ELISAICC/IFIHC |
| IHC:1:200-1:2000 ICC/IF:1:100-1:500 | |
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | BRCA1 |
|---|---|
| Gene Synonyms | BRCA-1 BRCAI BRCC1 BROVCA1 FANCS IRIS PNCA4 PPP1R53 PSCP RNF53 |
| Gene Full Name | BRCA1 DNA repair associated |
| Gene Summary | This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020] |
| Alternative Names | brca 1 brca-1 BRCA1/BRCA2-containing complex subunit 1 breast and ovarian cancer susceptibility protein breast and ovarian cancer susceptibility protein 1 breast and ovarian susceptibility protein breast cancer 1 early onset breast cancer 1 early onset breast cancer associated 1 breast cancer type 1 susceptibility protein isoform p.23 breast cancer type 1 susceptibility protein isoform p.10 breast cancer type 1 susceptibility protein isoform p.11 breast cancer type 1 susceptibility protein isoform p.12 breast cancer type 1 susceptibility protein isoform p.13 breast cancer type 1 susceptibility protein isoform p.14 breast cancer type 1 susceptibility protein isoform p.15 breast cancer type 1 susceptibility protein isoform p.16 breast cancer type 1 susceptibility protein isoform p.17 breast cancer type 1 susceptibility protein isoform p.18 breast cancer type 1 susceptibility protein isoform p.19 breast cancer type 1 susceptibility protein isoform p.20 breast cancer type 1 susceptibility protein isoform p.21 breast cancer type 1 susceptibility protein isoform p.22 breast cancer type 1 susceptibility protein isoform p.24 breast cancer type 1 susceptibility protein isoform p.25 breast cancer type 1 susceptibility protein isoform p.26 breast cancer type 1 susceptibility protein isoform p.27 breast cancer type 1 susceptibility protein isoform p.28 breast cancer type 1 susceptibility protein isoform p.29 breast cancer type 1 susceptibility protein isoform p.30 breast cancer type 1 susceptibility protein isoform p.31 breast cancer type 1 susceptibility protein isoform p.32 breast cancer type 1 susceptibility protein isoform p.33 breast cancer type 1 susceptibility protein isoform p.34 breast cancer type 1 susceptibility protein isoform p.35 breast cancer type 1 susceptibility protein isoform p.36 breast cancer type 1 susceptibility protein isoform p.37 breast cancer type 1 susceptibility protein isoform p.38 breast cancer type 1 susceptibility protein isoform p.39 breast cancer type 1 susceptibility protein isoform p.40 breast cancer type 1 susceptibility protein isoform p.41 breast cancer type 1 susceptibility protein isoform p.42 breast cancer type 1 susceptibility protein isoform p.6 breast cancer type 1 susceptibility protein isoform p.7 breast cancer type 1 susceptibility protein isoform p.8 breast cancer type 1 susceptibility protein isoform p.9 BROVCA12 Delta772-3095 early onset breast cancer 1 Fanconi anemia complementation group S human BRCA1 homolog Method: conceptual translation supplied by author influences susceptibility to breast and ovarian cancer OTTHUMP00000212147 OTTHUMP00000212148 OTTHUMP00000212149 OTTHUMP00000212150 OTTHUMP00000212151 OTTHUMP00000212155 protein phosphatase 1 regulatory subunit 53 RING finger protein 53 RING-type E3 ubiquitin transferase BRCA1 similar to human BRCA1 |
| Molecular Weight(MW) | 208KD |
| Cellular Localization | Chromosome, Cytoplasm, Nucleus |
| SwissProt ID | P38398 |
|---|
IHC
Immunohistochemical analysis of paraffin-embedded Human renal carcinoma tissues using BRCA1 antibody with DAB staining.Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6.0) (OM750020) for 2 minutes. Wash the sections with ddH₂O and PBS (OM750003). Block the tissue with 10% non-immune goat serum(OM760028) at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP (OM643487), at a ratio of 1:200 and incubate for one hour. Use DAB(OM760029)as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.
IHC
Immunohistochemical analysis of paraffin-embedded Human bladder cancer tissues using BRCA1 antibody with DAB staining.Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6.0) (OM750020) for 2 minutes. Wash the sections with ddH₂O and PBS (OM750003). Block the tissue with 10% non-immune goat serum(OM760028) at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP (OM643487), at a ratio of 1:200 and incubate for one hour. Use DAB(OM760029)as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.
ICC/IF
Immunofluorescence analysis of Hela cells using BRCA1 antibody (green). Blue: DAPI fluorescent DNA dye. Red: Actin filaments have been labeled with Omnimabs® 594-Phalloidin.Cells are fixed in 4% paraformaldehyde at room temperature for 20 minutes. Then, they are permeabilized with a PBS (OM750003) solution containing 0.1% Triton X-100(OM750021) at room temperature for 15 minutes. Subsequently, the cells are blocked with 10% non - immune goat serum(OM760028) at room temperature for 1 hour.The cells are incubated overnight at 4°C with the primary antibody diluted 1:100 in PBS. The secondary antibody, Omnimabs® 488 Goat Ant-Rabbit IgG(H&L) (Green,OM643486), is diluted at a ratio of 1:400 and incubated with the cells for 1 hour.Nuclear DNA is labeled with DAPI (Blue,OM643160). F-actin is stained with Omnimabs® 594-Phalloidin (Red,OM750007) diluted 1:100 for 30 minutes.
IHC
Immunohistochemical analysis of paraffin-embedded Human thyroid carcinoma tissues using BRCA1 antibody with DAB staining.Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6.0) (OM750020) for 2 minutes. Wash the sections with ddH₂O and PBS (OM750003). Block the tissue with 10% non-immune goat serum(OM760028) at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP (OM643487), at a ratio of 1:200 and incubate for one hour. Use DAB(OM760029)as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.
IHC
Immunohistochemical analysis of paraffin-embedded Human lung cancer tissues using BRCA1 antibody with DAB staining.Pre-treat the sections with heat-mediated antigen retrieval using sodium citrate buffer (pH 6.0) (OM750020) for 2 minutes. Wash the sections with ddH₂O and PBS (OM750003). Block the tissue with 10% non-immune goat serum(OM760028) at room temperature for 30 minutes. Incubate the tissue with the primary antibody diluted at a ratio of 1:1500 at 4°C overnight. At room temperature, dilute the secondary antibody, Goat Anti-Rabbit IgG(H&L)-HRP (OM643487), at a ratio of 1:200 and incubate for one hour. Use DAB(OM760029)as the chromogenic agent. Counterstain the tissue with hematoxylin, and mount the tissue sections with neutral gum.
ELISA
Coat the plate with immunizing antigen.Blue line： Immune serum; Orange line: Pre-immune serum.| Application Notes | IHC:1:200-1:2000 ICC/IF:1:100-1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
| Storage Buffer | Purified antibody in PBS with 0.05% sodium azide. |
抱歉，暂无相关文献
